Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trigonal-sparing Versus Trigonal-involved Intravesical Botulinumtoxin A Injection in Refractory Idiopathic Detrusor Overactivity.

NCT03533062 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT03533062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03533062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trigonal-sparing Versus Trigonal-involved Intravesical Botulinumtoxin A Injection in Refractory Idiopathic Detrusor Overactivity.
Lead sponsor
Mansoura University
Phase
Not applicable
Overall status
Completed
Start date
June 14, 2015
Completion date
May 30, 2018
Enrollment
80 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anticholinergic syndrome, overactive bladder syndrome, quality of life, urologic diseases